Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,776.80
(
-0.08%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.54
(
-1.91%
)
Bitcoin
70,497.40
(
-1.04%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 54
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: ghmm post# 44421

Thursday, 04/05/2007 7:40:31 PM

Thursday, April 05, 2007 7:40:31 PM

Post# of 257262
I'm not even sure most UTHR analysts know what OVaRex is or the potential it has if both trials are positive. The one worry of course is companies rarely sit on positive data... thought UTHR is not exactly "most companies" and REX has no control over the data release.

Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now